A strong research professional with over 20 years’ experience within the Pharmaceutical industry, working mainly in process development as a synthetic organic chemist. Had positions of increasing responsibility since starting at GSK, ranging from lab chemist and team manager through to Chemistry Manufacturing and Control (CMC) project manager. During my GSK career, I have led the primary development / delivery of 10 products, spanning early through to late phase development. Current roles are GSK CMC Due Diligence lead for small molecules and co-chair of the Genotoxic Risk Assessment (GRA) review team, where I am a GSK subject matter expert. To facilitate people development, I am also a practicing GSK Job Plus Coach, with seven years experience, and represent GSK on the Lhasa Mirabilis Pharmaceutical Consortium.
Scientific Director at GlaxoSmithKline
Post Doctoral Fellow, Organic Synthesis